Skip to main content
Clinical Trials/NCT01973088
NCT01973088
Unknown
Not Applicable

Screening and Identification of Human Urate Transporter hURAT1 MicroRNA

Qian-wei Li0 sites80 target enrollmentNovember 2013
ConditionsUrinary Calculi

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Urinary Calculi
Sponsor
Qian-wei Li
Enrollment
80
Primary Endpoint
micro-RNA
Last Updated
12 years ago

Overview

Brief Summary

This study intends to use in patients with renal tissue and blood samples, screening and identification of renal tissue hURAT1 regulating the expression of micro-RNA, for further study of uric acid stone formation mechanism and the occurrence of clinical preventive uric acid stones provide new clues and new intervention targets.

Registry
clinicaltrials.gov
Start Date
November 2013
End Date
June 2015
Last Updated
12 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Qian-wei Li
Responsible Party
Sponsor Investigator
Principal Investigator

Qian-wei Li

Southwest Hospital, China

Southwest Hospital, China

Eligibility Criteria

Inclusion Criteria

  • A、B group were enrolled standards: ① aged 18-65 years old; ② comply with percutaneous nephrolithotomy lithotripsy indications for surgery; ③ ECT tips ipsilateral normal or mildly impaired renal function.
  • Group C patients were enrolled standards: ① aged 18-65 years old; ② normal renal function, not associated with urinary calculi in patients; ③ cancer patients met radical nephrectomy indications for surgery; ④ emergency trauma patients suffering from kidney resection surgical indications.

Exclusion Criteria

  • aged \<18 years or\> 65 years; ② neurological disease or cognitive dysfunction; ③ can not be corrected or uncorrected coagulopathy; ④ associated with diabetes, hypertension and other metabolic diseases; ⑤ accompanied by tuberculosis, hepatitis, HIV and other infectious diseases; ⑥ poor tolerance to anesthesia and surgery, such as: severe cardiopulmonary disease, coagulation disorders, etc.; ⑦ ultrasound, renal imaging examination revealed renal cortex was significantly thinner (renal cortical thickness \<1.5cm), structural variation; ⑧ with severe systemic or urinary tract infection; ⑨ ECT tips ipsilateral renal function is severely impaired or solitary kidney.

Outcomes

Primary Outcomes

micro-RNA

Time Frame: 6 months

microRNA microarray:the micro-RNA of kidney tissue

Secondary Outcomes

  • 24h urine quantitative analysis(96 hours)
  • Urine(24 hours)
  • Blood biochemistry(24 hours)
  • Stone analysis(3 weeks)
  • hURAT1 transporter protein(6 months)

Similar Trials